BRIEF published on 10/13/2026 at 18:15, 2 days 10 hours ago Medincell Secures €41.8 Million in Non-Dilutive Financing Debt Maturity Non-dilutive Financing Biopharmaceuticals European Investment Bank Medincell
BRIEF published on 10/13/2026 at 18:15, 2 days 10 hours ago Medincell strengthens its financing with a new non-dilutive loan Treasury Funding Biopharmaceutical Medincell Non-dilutable
PRESS RELEASE published on 10/13/2026 at 18:10, 2 days 10 hours ago Inside Information / Other news releases Medincell secures €13.8 million non-dilutive financing, totaling €41.8 million. Debt maturity extended through 2031. No equity instruments used for financing Debt Maturity Non-dilutive Financing Bpifrance Medincell European Commercial Banks
BRIEF published on 10/09/2026 at 15:03, 6 days 13 hours ago Medincell shares resume trading on Euronext Paris FDA Euronext Medincell Teva Olanzapine LAI
BRIEF published on 10/09/2026 at 15:03, 6 days 13 hours ago Medincell Resumes Trading on Euronext Paris Euronext Paris FDA Approval Trading Resumption Medincell BEPO Technology
PRESS RELEASE published on 10/09/2026 at 14:58, 6 days 13 hours ago Inside Information / Other news releases Medincell resumes trading on Euronext Paris after temporary suspension. The company specializes in long-acting injectable treatments using innovative technologies Innovation Euronext Paris Trading Medincell Long-acting Injectable Treatments
BRIEF published on 10/09/2026 at 14:01, 6 days 14 hours ago Medincell receives FDA approval for WELTRUZA™ FDA Schizophrenia Medincell Olanzapine WELTRUZA™
PRESS RELEASE published on 10/09/2026 at 13:56, 6 days 14 hours ago Inside Information / Other news releases Medincell achieves major milestone with U.S. FDA approval of WELTRUZA™ (olanzapine), offering a new treatment option for adults with schizophrenia FDA Approval Schizophrenia Medincell Long-acting Injectable WELTRUZA
BRIEF published on 10/09/2026 at 09:43, 6 days 19 hours ago Medincell Temporarily Suspends Trading on Euronext Paris Euronext Paris Biopharmaceuticals Trading Suspension Medincell BEPO Technology
PRESS RELEASE published on 10/09/2026 at 09:38, 6 days 19 hours ago Inside Information / Other news releases Medincell temporarily suspends trading of its shares on Euronext Paris pending a press release, focusing on long-acting injectable treatments and innovative therapeutic candidates Euronext Paris Suspension Therapeutic Candidates Medincell Long-acting Injectable Treatments
Published on 10/16/2026 at 02:10, 2 hours 45 minutes ago Nova Scotia Silver Explorer TruSilver Metals Corp. Anticipates TSXV Trading Under "TAG" on October 27
Published on 10/16/2026 at 01:45, 3 hours 10 minutes ago Faraday Copper Closes the Acquisition of the San Manuel Project in Arizona and Mobilizes Drill Rigs
Published on 10/16/2026 at 01:30, 3 hours 25 minutes ago LNG Energy Group Announces Closing of Second Tranche of Private Placement
Published on 10/15/2026 at 23:08, 5 hours 47 minutes ago ACCESS Newswire to Present at the 20th Annual LD Micro Main Event XX - Tuesday October 20, 2026 - 11:00AM PT (2:00PM ET)
Published on 10/15/2026 at 23:05, 5 hours 50 minutes ago EXIM Reiterates Target to Finance Approximately 65% of Elk Creek Project Upfront CAPEX
Published on 10/15/2026 at 22:30, 6 hours 25 minutes ago Porsche Mission S: the essence of the sports car reinterpreted
Published on 10/15/2026 at 20:30, 8 hours 25 minutes ago Nordex Group reports strong preliminary Q3/2026 results and raises EBITDA margin guidance for full year 2026
Published on 10/15/2026 at 20:28, 8 hours 26 minutes ago EQS-Adhoc: Nordex SE: Nordex Group reports strong preliminary Q3/2026 results and raises EBITDA margin guidance for full year 2026
Published on 10/15/2026 at 18:03, 10 hours 52 minutes ago AIXTRON Q3 2026: Order intake and operating profitability significantly exceed market expectations
Published on 10/15/2026 at 18:50, 10 hours 5 minutes ago September & first 9 months of 2026 traffic figures - Revision of Traffic assumptions for 2026
Published on 10/15/2026 at 17:45, 11 hours 10 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 10/15/2026 at 07:27, 21 hours 27 minutes ago Saint-Gobain strengthens its infrastructure offer in North America with the acquisition of D.S. Brown in construction chemicals
